» Articles » PMID: 20463863

Behavioral, Physiological and Biochemical Hormetic Responses to the Autoxidizable Dye Methylene Blue

Overview
Specialty Pharmacology
Date 2011 Sep 28
PMID 20463863
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

The goals of this review were to identify methylene blue (MB) as a compound that follows hormetic behavior for a wide range of effects and to address the question of what is unique about MB that could account for its wide applicability and hormetic behavior as a drug. The MB hormetic dose-response relationship is exemplified by an increase in various behavioral, physiological and biochemical responses with increasing dose, followed by a decrease in the same responses with an even higher dose, until the responses are equal to control responses. With MB doses increasing beyond the hormetic zone, the responses decrease even further, until they are below the control responses. At doses spanning its hormetic zone, MB can increase select responses until they are 130-160% of control. For example, low doses of MB produce maximum behavioral and biochemical responses with averages of approximately 140% of control. As MB dose is raised outside the hormetic zone the response decreases below the control response, as exemplified by MB's ability to increase cytochrome oxidase activity at intermediate doses, while decreasing cytochrome oxidase activity at higher doses. It is proposed that MB's autoxidizable chemical property may be responsible for its unique biological action as both a metabolic energy enhancer and antioxidant that is frequently characterized by hormetic dose-response relationships.

Citing Articles

Metabolic Shift and Hyperosmolarity Underlie Age-Related Macular Degeneration.

Schwartz L, Schwartz J, Henry M, Bakkar A Life (Basel). 2024; 14(9).

PMID: 39337971 PMC: 11432886. DOI: 10.3390/life14091189.


Methylene Blue Pretreatment Protects Against Repeated Neonatal Isoflurane Exposure-Induced Brain Injury and Memory Loss.

Wu C, Deng Q, Zhu L, Liu T, Duan R, Yang L Mol Neurobiol. 2024; 61(8):5787-5801.

PMID: 38233687 DOI: 10.1007/s12035-024-03931-0.


The effects of acute Methylene Blue administration on cerebral blood flow and metabolism in humans and rats.

Singh N, MacNicol E, Dipasquale O, Randall K, Lythgoe D, Mazibuko N J Cereb Blood Flow Metab. 2023; 43(2_suppl):95-105.

PMID: 36803299 PMC: 10638993. DOI: 10.1177/0271678X231157958.


Tunable alginate hydrogels as injectable drug delivery vehicles for optic neuropathy.

Maxwell C, Soltisz A, Rich W, Choi A, Reilly M, Swindle-Reilly K J Biomed Mater Res A. 2022; 110(10):1621-1635.

PMID: 35607724 PMC: 9543600. DOI: 10.1002/jbm.a.37412.


A focus on natural products for preventing and cure of mitochondrial dysfunction in Parkinson's disease.

Mohammadipour A Metab Brain Dis. 2022; 37(4):889-900.

PMID: 35156154 DOI: 10.1007/s11011-022-00931-8.


References
1.
Riha P, Bruchey A, Echevarria D, Gonzalez-Lima F . Memory facilitation by methylene blue: dose-dependent effect on behavior and brain oxygen consumption. Eur J Pharmacol. 2005; 511(2-3):151-8. DOI: 10.1016/j.ejphar.2005.02.001. View

2.
Burrows G . Methylene blue: effects and disposition in sheep. J Vet Pharmacol Ther. 1984; 7(3):225-31. DOI: 10.1111/j.1365-2885.1984.tb00904.x. View

3.
Yusim Y, Livingstone D, Sidi A . Blue dyes, blue people: the systemic effects of blue dyes when administered via different routes. J Clin Anesth. 2007; 19(4):315-21. DOI: 10.1016/j.jclinane.2007.01.006. View

4.
Pfaffendorf M, Bruning T, Batnik H, van Zwieten P . The interaction between methylene blue and the cholinergic system. Br J Pharmacol. 1997; 122(1):95-8. PMC: 1564911. DOI: 10.1038/sj.bjp.0701355. View

5.
Visarius T, Stucki J, Lauterburg B . Stimulation of respiration by methylene blue in rat liver mitochondria. FEBS Lett. 1997; 412(1):157-60. DOI: 10.1016/s0014-5793(97)00767-9. View